Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. Signal., 23 December 2008
Vol. 1, Issue 51, p. ra17
[DOI: 10.1126/scisignal.1164795]
RESEARCH ARTICLES
Type I IL-4Rs Selectively Activate IRS-2 to Induce Target Gene Expression in Macrophages
Nicola M. Heller1,2,
Xiulan Qi1,2,
Ilkka S. Junttila3,
Kari Ann Shirey2,
Stefanie N. Vogel2,
William E. Paul3, and
Achsah D. Keegan1,2*
1 Center for Vascular and Inflammatory Diseases, Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, USA. 2 Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA. 3 Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
Although interleukin-4 (IL-4) and IL-13 participate in allergic inflammation and share a receptor subunit (IL-4R), they have different functions. We compared cells expressing type I and II IL-4Rs with cells expressing only type II receptors for their responsiveness to these cytokines. IL-4 induced highly efficient, C-dependent tyrosine phosphorylation of insulin receptor substrate 2 (IRS-2), whereas IL-13 was less effective, even when phosphorylation of signal transducer and activator of transcription 6 (STAT6) was maximal. Only type I receptor, C-dependent signaling induced efficient association of IRS-2 with the p85 subunit of phosphoinositide 3-kinase or the adaptor protein growth factor receptor–bound protein 2. In addition, IL-4 signaling through type I IL-4Rs induced more robust expression of a subset of genes associated with alternatively activated macrophages than did IL-13. Thus, IL-4 activates signaling pathways through type I IL-4Rs qualitatively differently from IL-13, which cooperate to induce optimal gene expression.
* To whom correspondence should be addressed. E-mail: akeegan{at}som.umaryland.edu
Citation: N. M. Heller, X. Qi, I. S. Junttila, K. A. Shirey, S. N. Vogel, W. E. Paul, A. D. Keegan, Type I IL-4Rs Selectively Activate IRS-2 to Induce Target Gene Expression in Macrophages. Sci. Signal.1, ra17 (2008).
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Kristen L. Mueller (12 April 2011) Sci. Signal.4 (168), ec101.
[DOI: 10.1126/scisignal.4168ec101] |Abstract »
EDITORIAL GUIDES
John F. Foley and Nancy R. Gough (19 January 2010) Sci. Signal.3 (105), eg2.
[DOI: 10.1126/scisignal.3105eg2] |Abstract »|Full Text »|PDF »
PERSPECTIVES
Marsha Wills-Karp and Fred D. Finkelman (23 December 2008) Sci. Signal.1 (51), pe55.
[DOI: 10.1126/scisignal.1.51.pe55] |Abstract »|Full Text »|PDF »
DATABASE OF CELL SIGNALING
Interleukin 4 (IL-4) Pathway
Ann E. Kelly-Welch, Erica M. Hanson and Achsah D. Keegan Sci. Signal. (Connections Map Pathway), http://stke.sciencemag.org/cgi/cm/stkecm;CMP_7740 |Overview »|Canonical Pathway »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Dissociation of Endotoxin Tolerance and Differentiation of Alternatively Activated Macrophages.
R. Rajaiah, D. J. Perkins, S. K. Polumuri, A. Zhao, A. D. Keegan, and S. N. Vogel (2013)
J. Immunol.
190, 4763-4772
|Abstract »|Full Text »|PDF »
Cytokine Stimulation of Epithelial Cancer Cells: The Similar and Divergent Functions of IL-4 and IL-13.
M. A. Hallett, K. T. Venmar, and B. Fingleton (2012)
Cancer Res.
72, 6338-6343
|Abstract »|Full Text »|PDF »
Regulation of inflammation by interleukin-4: a review of "alternatives".
I. G. Luzina, A. D. Keegan, N. M. Heller, G. A. W. Rook, T. Shea-Donohue, and S. P. Atamas (2012)
J. Leukoc. Biol.
92, 753-764
|Abstract »|Full Text »|PDF »
The Extracellular and Transmembrane Domains of the {gamma}C and Interleukin (IL)-13 Receptor {alpha}1 Chains, Not Their Cytoplasmic Domains, Dictate the Nature of Signaling Responses to IL-4 and IL-13.
N. M. Heller, X. Qi, F. Gesbert, and A. D. Keegan (2012)
J. Biol. Chem.
287, 31948-31961
|Abstract »|Full Text »|PDF »
Cytokine Pathways in Allergic Disease.
C. M. M. Williams, S. Rahman, C. Hubeau, and H.-L. Ma (2012)
Toxicol Pathol
40, 205-215
|Abstract »|Full Text »|PDF »
Hierarchical IL-5 Expression Defines a Subpopulation of Highly Differentiated Human Th2 Cells.
B. Upadhyaya, Y. Yin, B. J. Hill, D. C. Douek, and C. Prussin (2011)
J. Immunol.
187, 3111-3120
|Abstract »|Full Text »|PDF »
SHIP-deficient, alternatively activated macrophages protect mice during DSS-induced colitis.
S. B. Weisser, H. K. Brugger, N. S. Voglmaier, K. W. McLarren, N. van Rooijen, and L. M. Sly (2011)
J. Leukoc. Biol.
90, 483-492
|Abstract »|Full Text »|PDF »
Expression of IL-4/IL-13 receptors in differentiating human airway epithelial cells.
S. R. White, L. D. Martin, R. Stern, B. Laxman, and B. A. Marroquin (2010)
Am J Physiol Lung Cell Mol Physiol
299, L681-L693
|Abstract »|Full Text »|PDF »
Importance of Cytokines in Murine Allergic Airway Disease and Human Asthma.
F. D. Finkelman, S. P. Hogan, G. K. K. Hershey, M. E. Rothenberg, and M. Wills-Karp (2010)
J. Immunol.
184, 1663-1674
|Abstract »|Full Text »|PDF »
Untangling the Complex Web of IL-4- and IL-13-Mediated Signaling Pathways.